Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aerovate Therapeutics ( (AVTE) ) has provided an announcement.
Maha Katabi, Ph.D., has resigned from Aerovate Therapeutics’ board of directors and its Audit and Compensation Committees, effective October 6, 2024. Her departure is voluntary and without any disputes related to the company’s operations or policies. The Board has expressed appreciation for Dr. Katabi’s service and contributions to the company.
See more insights into AVTE stock on TipRanks’ Stock Analysis page.